Current Situation and Future of Drug Clinical Trial Management in China
In the background of the reform of drug review and approval system, great changes have taken place in China’s drug clinical trial management regulations. The main changes include: the change of clinical trial institutions from accreditation to fi ling system, the change of clinical trial approval from express approval system to implied approval system, and the implementation of China GCP（2020 version）. The future of China’s drug clinical trial management will usher in the improvement of clinical trial quality, technical challenges and industry changes.
drug, clinical trial, GCP, drug clinical trial institution, license
梁愛華※1 潘 辰 韓佳寅 田婧卓
Advances of new drug research of traditional Chinese medicine in China
There is a long history of using traditional Chinese medicine（TCM）to treat diseases in China, and a large number of TCM formulas have been documented during the long-term clinical practice. These materia medica and formulas with their clinical experiences are rich resources for the development of new drugs. This article introduces the classifi cation and requirements of TCM new drugs in China, the approaches for TCM new drug discovery, and the representative new drugs of traditional Chinese Medicine, so as to provide references for new drug developers.
Traditional Chinese medicine, formula of traditional Chinese medicine, new drug registration, new drug research and development, classifi cation of traditional Chinese medicine
株式会社医療システム研究所 治験推進本部 取締役本部長
Current status of clinical trials and clinical research in Japan, Consideration for problems of clinical trial, and prospects
Clinical trials in Japan, it is said to be special compared to those of Western countries and Asian countries. I would like to describe the current status and issues of clinical trials in Japan from my experience of being involved in clinical development at a pharmaceutical company, later working for SMO for many years, and serving as a lecturer at a pharmacy school and a nursing university.
GCP（Good Clinical Practice）, Global clinical trial, clinical research coordinator, drug lag
IQVIA サービシーズ ジャパン株式会社 シニアディレクター
Clinical Drug Development and Clinical Trial：Current Status, Prospects and Challenges
There are challenges in the pharmaceutical industry. The Japanese market is experiencing negative growth and it is more difficult to approve new drugs for investment. Under these circumstances, discussions on productivity and efficiency in drug research and development are intensifying. In addition to trends such as Precision Medicine and Patient Centricity, digitalization represented by “Virtual Trial” is progressing in the implementation of clinical trials and expected to improve productivity/efficiency.
Clinical Trial, Productivity, Efficiency, Virtual Trial
笹川生 in China